The activation and overexpression of FXR specifically in PTs reduce lipid accumulation during cisplatin-induced AKI by improving FAO by activating the transcription of PPARγ and carnitine palmitoyltransferase (CPT1), a rate-limiting enzyme in FAO10. The gene discussed is NR1H4; the disease is acute kidney injury.